MedTrace Logo

Does Ascorbic Acid Reduce Sympathoexcitation in CHF?

NCT00550121 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2008-10-15

No results posted yet for this study

Summary

In CHF central sympathetic activity is increased. ROS formation seems to play a role in this process. This study analyzes the effect of vitamin C as an antioxidant on central sympathetic activity in CHF

Conditions

Interventions

DRUG

vitamin C

DRUG

placebo

Sponsors & Collaborators

  • ZonMw: The Netherlands Organisation for Health Research and Development

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Cees J Tack, MD, PhD · Radboud University Medical Centre Nijmegen

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Completion
2008-04-30

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00550121 on ClinicalTrials.gov